Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
Milja Belik, Pinja Jalkanen, Rickard Lundberg, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Is a booster dose of COVID-19 vaccines effective on newly dominant omicron subvariants among university students? Comparison between BA.1 and BA.2 dominancy
Shunsuke Miyauchi, Toru Hiyama, Yukiko Nakano, et al.
American Journal of Infection Control (2022) Vol. 51, Iss. 8, pp. 907-911
Open Access | Times Cited: 9
Long-term levels of protection of different types of immunity against the Omicron variant: a rapid literature review
Sabina Rodriguez Velásquez, Loza Biru, Sandrine Marie Hakiza, et al.
Schweizerische medizinische Wochenschrift (2024) Vol. 154, Iss. 5, pp. 3732-3732
Open Access | Times Cited: 1
Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections
Kathryn Macrae, Jorge Martínez-Cajas, Kristin Bessai, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 7059-7071
Open Access | Times Cited: 8
Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings
Yunes Panahi, Behzad Einollahi, Fatemeh Beiraghdar, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Antibody Response Induced by BNT162b2 and mRNA-1273 Vaccines against the SARS-CoV-2 in a Cohort of Healthcare Workers
Juan F. Delgado, Antonio Berenguer, Germà Julià, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1235-1235
Open Access | Times Cited: 7
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)
Flor M. Muñoz, Christine M. Posavad, Barbra A. Richardson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Early CD4+ T cell responses induced by the BNT162b2 SARS-CoV-2 mRNA vaccine predict immunological memory
Jie Bai, Asako Chiba, Goh Murayama, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases
Yongmei Liu, Jianhua Lu, Haoting Zhan, et al.
Virologica Sinica (2023) Vol. 38, Iss. 5, pp. 723-734
Open Access | Times Cited: 3
Retrospective Cohort Study of COVID-19 in Patients of the Brazilian Public Health System with SARS-CoV-2 Omicron Variant Infection
Thiago B. Murari, Larissa Moraes dos Santos Fonseca, Hernane Borges de Barros Pereira, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1504-1504
Open Access | Times Cited: 5
Quantitative Analysis of SARS-CoV-2 Serological Responses Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections
Kathryn Macrae, Catherine Yuqing Gong, Prameet M. Sheth, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1590-1590
Open Access | Times Cited: 5
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
Ahmed M. Awad, Kamryn Hansen, Diana Del Rio, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1452-1452
Open Access | Times Cited: 2
Results of the Cologne Corona Surveillance (CoCoS) project– a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection, and moderate-to-severe course in primarily immunized adults
Max Oberste, Teodora Asenova, Angela Ernst, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access
SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Sclerosis
Ryan M. Baxter, Berenice Cabrera-Martinez, Tusharkanti Ghosh, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 254-268
Open Access
Neutralizing antibody responses to SARS-CoV-2 Omicron variants: Post six months following two-dose & three-dose vaccination of ChAdOx1 nCoV-19 or BBV152
Pragya D. Yadav, Viren Sardana, Gururaj Deshpande, et al.
The Indian Journal of Medical Research (2024) Vol. 159, Iss. 2, pp. 223-223
Open Access
Comparison of long-term anti-RBD SARS-CoV-2 antibody response following different vaccination schemes in Tunisia
Awatef Ben Jemaa, Rihab Bouabsa, Meriam Ben Othmen, et al.
La Tunisie Médicale (2024) Vol. 102, Iss. 8
Closed Access
Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum
Flor M. Muñoz, Richard Beigi, Christine M. Posavad, et al.
The Pediatric Infectious Disease Journal (2024) Vol. 43, Iss. 11, pp. 1065-1073
Closed Access
An overview of SARS-CoV-2 viral proteins with relevance to improved diagnostic and therapeutic platforms
Christopher Chung, Pratiba Irudayaraj, Emran O. Lallow, et al.
Frontiers in Virology (2024) Vol. 4
Open Access
Genomic characteristics, disease outcome and heterologous vaccine effectiveness among cases with SARS CoV-2 infection
Rowan Abuyadek, Mira Mousa, Jumana AlAzazi, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity
Milja Belik, Arttu Reinholm, Pekka Kolehmainen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies
Reham F. Barghash, Donato Gemmati, Ahmed M. Awad, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5564-5564
Open Access
COVID-19 Rapid Antigen Tests: Bibliometric Analysis of the Scientific Literature
Andy Wai Kan Yeung, Emil D. Parvanov, Faisal A. Nawaz, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 12493-12493
Open Access | Times Cited: 3
Monthly Fluctuation of Spike Protein-specific IgG Antibody Level against COVID-19 after COVID-19 Vaccination and Booster Shot
Ikuma Kasuga, Yoshimi Yokoe, Yuko Ishii, et al.
(2022) Vol. 3, Iss. 3
Open Access | Times Cited: 3
Stable and durable antibody responses in SARS‐recovered donors vaccinated with inactivated SARS‐CoV‐2 vaccine
Tingting Jia, Yuankai Wu, Guancheng Liao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 1
Kinetics of SARS-CoV-2 Spike Antibodies after the Second and Third Dose of the BNT162b2 COVID-19 Vaccine and Association with Epidemiological Characteristics and Breakthrough Infection in a Cohort Study of Healthcare Workers
Elizabeth‐Barbara Tatsi, Filippos Filippatos, Charilaos Dellis, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2010-2010
Open Access | Times Cited: 1
Antibody titer 6 months after the third dose of COVID-19 mRNA vaccination
Rikei Kozakai, Susumu Suzuki, Kuniko Hoshi, et al.
Journal of Laboratory Medicine (2022) Vol. 47, Iss. 1, pp. 41-45
Open Access | Times Cited: 1

Scroll to top